differences in glp 1 drugs Indications for GLP-1/GIP RA Summary Sheet and Beyond! The GLP-1 Agonists and Obesity:

Both technologies eliminate daily dosing facilitated by their subcutaneous placement, which avoids first-pass metabolism and gastrointestinal degradation

Diabetes Care 2017

a) Glucagon like peptide (GLP-1 receptor agonist) b) Glucose Dependant Insuli notrophic Polypetide (GIP) GLP-1: Enhances binding to GLP-1 receptor and inhibit it from binding to DDP4 (the enzyme responsible for Incretin degredation)

Methods Using MarketScan claims and encounters data, 12 we included individuals with 1 year of enrollment and who were eligible for prescription coverage (N=27,240,373)

The KwikPen and single-dose vial formulations of Lilly's Zepbound cost from $299 to $699 per month, depending on the dose

PMID: 38639975.